platinum and HIV
platinum has been researched along with HIV in 4 studies
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Agarwal, S; Brookes, JC; Chudasama, V; Gray, ER; Kim, J; Loynachan, CN; McKendry, RA; Miller, BS; Richards, DA; Stevens, MM; Thomas, MR | 1 |
| Bate, AB; Bayse, CA; Dows, MG; Farrell, NP; Spell, SR; Tsotsoros, SD | 1 |
| Darkwa, J; Elkhadir, AY; Gama, NH; Gordhan, BG; Kana, BD; Meyer, D | 1 |
| Dowdeswell, RJ; Field, N; Glynn, JR; Lim, MS; Murray, J; Sonnenberg, P | 1 |
Other Studies
4 other study(ies) available for platinum and HIV
| Article | Year |
|---|---|
Platinum Nanocatalyst Amplification: Redefining the Gold Standard for Lateral Flow Immunoassays with Ultrabroad Dynamic Range.
Topics: Antibodies, Immobilized; Catalysis; Equipment Design; Gold; HIV; HIV Core Protein p24; HIV Infections; Humans; Immunoassay; Metal Nanoparticles; Platinum; Point-of-Care Testing; Porosity | 2018 |
Modulation of the stacking interaction of MN4 (M=Pt, Pd, Au) complexes with tryptophan through N-heterocyclic ligands.
Topics: Amino Acid Sequence; Coordination Complexes; Gold; Heterocyclic Compounds; HIV; Humans; Ligands; Magnetic Resonance Spectroscopy; Molecular Structure; Palladium; Platinum; Tryptophan; Zinc Fingers | 2014 |
Activity of phosphino palladium(II) and platinum(II) complexes against HIV-1 and Mycobacterium tuberculosis.
Topics: Anti-HIV Agents; Antitubercular Agents; Cell Line; Dose-Response Relationship, Drug; HIV; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Organometallic Compounds; Palladium; Phosphines; Platinum; Structure-Activity Relationship | 2016 |
The impact of HIV, an antiretroviral programme and tuberculosis on mortality in South African platinum miners, 1992-2010.
Topics: Adult; Antiretroviral Therapy, Highly Active; Cause of Death; HIV; HIV Infections; HIV Seropositivity; Humans; Male; Middle Aged; Mining; Mortality; Mycobacterium; Platinum; Prognosis; Retrospective Studies; Risk Factors; South Africa; Survival Rate; Time Factors; Tuberculosis | 2012 |